- Home
- HEPA vs SGD Comparison
HEPA vs SGD Comparison
Compare HEPA & SGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HEPA
- SGD
- Stock Information
- Founded
- HEPA 2013
- SGD 2021
- Country
- HEPA United States
- SGD United States
- Employees
- HEPA N/A
- SGD N/A
- Industry
- HEPA Biotechnology: Pharmaceutical Preparations
- SGD
- Sector
- HEPA Health Care
- SGD
- Exchange
- HEPA Nasdaq
- SGD Nasdaq
- Market Cap
- HEPA 4.1M
- SGD 3.4M
- IPO Year
- HEPA N/A
- SGD N/A
- Fundamental
- Price
- HEPA $0.57
- SGD $2.22
- Analyst Decision
- HEPA Hold
- SGD
- Analyst Count
- HEPA 1
- SGD 0
- Target Price
- HEPA N/A
- SGD N/A
- AVG Volume (30 Days)
- HEPA 27.9K
- SGD 127.8K
- Earning Date
- HEPA 11-14-2024
- SGD 01-01-0001
- Dividend Yield
- HEPA N/A
- SGD N/A
- EPS Growth
- HEPA N/A
- SGD N/A
- EPS
- HEPA N/A
- SGD N/A
- Revenue
- HEPA N/A
- SGD $173,188.00
- Revenue This Year
- HEPA N/A
- SGD N/A
- Revenue Next Year
- HEPA N/A
- SGD N/A
- P/E Ratio
- HEPA N/A
- SGD N/A
- Revenue Growth
- HEPA N/A
- SGD N/A
- 52 Week Low
- HEPA $0.48
- SGD $1.45
- 52 Week High
- HEPA $3.72
- SGD $53.80
- Technical
- Relative Strength Index (RSI)
- HEPA 39.66
- SGD 40.85
- Support Level
- HEPA $0.48
- SGD $2.05
- Resistance Level
- HEPA $0.66
- SGD $2.40
- Average True Range (ATR)
- HEPA 0.06
- SGD 0.24
- MACD
- HEPA -0.01
- SGD 0.05
- Stochastic Oscillator
- HEPA 32.88
- SGD 26.32
About HEPA Hepion Pharmaceuticals Inc.
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan-cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.
About SGD Safe and Green Development Corporation
Safe & Green Development Corp is a real estate development company that focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe & Green Holdings factories. The company's business model is flexible and it anticipates developing properties on its own and also through joint ventures in which it partner with third-party equity investors or other developers.